These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 21426094)
1. Clinical trials in developing countries: risk or opportunity? Saint Raymond A; Sweeney F Future Med Chem; 2009 Oct; 1(7):1193-5. PubMed ID: 21426094 [No Abstract] [Full Text] [Related]
2. Approaches vary for clinical trials in developing countries. Hayasaka E J Natl Cancer Inst; 2005 Oct; 97(19):1401-3. PubMed ID: 16204687 [No Abstract] [Full Text] [Related]
4. For-profit clinical trials in developing countries--those troublesome patient benefits. Schuklenk U Am J Bioeth; 2010 Jun; 10(6):52-4. PubMed ID: 20526975 [No Abstract] [Full Text] [Related]
5. Human rights: the normative engine of fairness and research in developing countries. McMillan J Am J Bioeth; 2010 Jun; 10(6):47-9. PubMed ID: 20526973 [No Abstract] [Full Text] [Related]
6. The promise and pitfalls of clinical trials overseas. Normile D Science; 2008 Oct; 322(5899):214-6. PubMed ID: 18845744 [No Abstract] [Full Text] [Related]
7. Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust? Yearby R De Paul Law Rev; 2004; 53(3):1127-54. PubMed ID: 16200692 [No Abstract] [Full Text] [Related]
8. Ethical considerations of clinical trials in the developing world. Fitchett JR Trans R Soc Trop Med Hyg; 2009 Aug; 103(8):756-60. PubMed ID: 19345967 [TBL] [Abstract][Full Text] [Related]
9. Assuring the ethical conduct of clinical cancer trials in the developing world. Markman M Cancer; 2006 Jan; 106(1):1-3. PubMed ID: 16302227 [No Abstract] [Full Text] [Related]
10. Why adopt a maximin theory of exploitation? Wertheimer A; Millum J; Schaefer GO Am J Bioeth; 2010 Jun; 10(6):38-9. PubMed ID: 20526968 [No Abstract] [Full Text] [Related]
11. Multiple forms of exploitation in international research: the need for multiple standards of fairness. Snyder J Am J Bioeth; 2010 Jun; 10(6):40-1. PubMed ID: 20526969 [No Abstract] [Full Text] [Related]
12. Undue fear of inducements in research in developing countries. Arnason G; Van Niekerk A Camb Q Healthc Ethics; 2009 Apr; 18(2):122-9. PubMed ID: 19250565 [No Abstract] [Full Text] [Related]
13. Justice in the application of science: beyond fair benefits. London AJ Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976 [No Abstract] [Full Text] [Related]
14. Prior agreements in international clinical trials: ensuring the benefits of research to developing countries. Page AK Yale J Health Policy Law Ethics; 2002; 3(1):35-66. PubMed ID: 12825426 [No Abstract] [Full Text] [Related]
15. Conducting clinical trials on tuberculosis in resource-poor countries: imposed science or equally-shared efforts? Lienhardt C; Cook SV Int J Tuberc Lung Dis; 2005 Sep; 9(9):943. PubMed ID: 16158884 [No Abstract] [Full Text] [Related]
16. Clinical trials of drugs and vaccines among the desperately poor in poor nations: ethical challenges and ethical solutions. Caplan AL Clin Pharmacol Ther; 2010 Nov; 88(5):583-4. PubMed ID: 20959841 [TBL] [Abstract][Full Text] [Related]
17. The European and developing countries clinical trails partnership. Olliaro P; Smith PG J HIV Ther; 2004 Sep; 9(3):53-6. PubMed ID: 15534561 [TBL] [Abstract][Full Text] [Related]
18. [Clinical trials in developing countries: who should define ethics?]. Béréterbide F; Hirsch F Bull Soc Pathol Exot; 2008 Apr; 101(2):102-5. PubMed ID: 18543701 [TBL] [Abstract][Full Text] [Related]
19. Research in developing countries. Shann F N Engl J Med; 2002 Feb; 346(8):627-8. PubMed ID: 11856807 [No Abstract] [Full Text] [Related]
20. In that case: your company has invested heavily in developing an AIDS vaccine and wishes to embark on clinical trials. Commentary. Evans D N Z Bioeth J; 2001 Oct; 2(3):37-8. PubMed ID: 15587008 [No Abstract] [Full Text] [Related] [Next] [New Search]